glp 1 weight loss medications GLP-1 Drugs from the Gray Market The GLP-1 revolution: What UAB

Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks

Ozempic insurance coverage One of the main challenges with GLP-1 medication is getting approved for insurance

CMS currently lists eligible drugs for weight reduction and weight maintenance under the Medicare GLP-1 Bridge as: Foundayo Wegovy , including injection and tablets Zepbound , limited to the KwikPen formulation The list may change during the program

On a 30-unit syringe with half-unit markings, each small line represents 0.5 units